Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.

Biotechnology

Galecto

Galecto's headquarters in København, Denmark

Hans T. Schambye

Lori C. Firmani, CPA, MBA

Rob Slack, FRSB

Frank L.

Garrett Winslow

Hakon Leffler

Jayson Dallas

Amit D. Munshi

Carl Goldfischer

Ulf Nilsson

Tariq Sethi

Anne Prener

The Directors and Vice Presidents at Galecto form a leadership team responsible for strategic decision-making and overseeing the execution of key functions. They guide various departments such as pharmacology, medical affairs, clinical operations, finance, and project management, ensuring that the company's initiatives in developing novel small molecule therapeutics for fibrosis, inflammation, and cancer are effectively managed and aligned with corporate goals.

Directors and Vice Presidents

The Leadership Team at Galecto is responsible for setting the strategic direction of the company and overseeing its operations. Comprised of founders and executives with diverse expertise, the team drives innovation in the development of novel therapeutics, ensures alignment with the company’s mission to combat fibrosis, inflammation, and cancer, and fosters partnerships to advance clinical programs.

Leadership Team

This department is responsible for guiding the strategic direction and ensuring compliance at the highest organizational level.

��

Galecto

Org chart

Board & advisors

Teams

Directors and Vice Presidents

Leadership Team

Governance and Oversight

Offices

��������

Galecto

Org chart

Board & advisors

Teams

Directors and Vice Presidents

Leadership Team

Governance and Oversight

Offices

Related companies

��